Have a feature idea you'd love to see implemented? Let us know!

NARI Inari Medical Inc

Price (delayed)

$51.39

Market cap

$3.01B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.35

Enterprise value

$3B

Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Inari has developed two minimally-invasive, ...

Highlights
The revenue rose by 22% year-on-year and by 4.9% since the previous quarter
NARI's gross profit is up by 20% YoY and by 4.5% QoQ
The equity is down by 3.8% year-on-year but it is up by 2.6% since the previous quarter
The quick ratio has plunged by 79% YoY and by 4.3% from the previous quarter
NARI's net income is down by 38% since the previous quarter

Key stats

What are the main financial stats of NARI
Market
Shares outstanding
58.54M
Market cap
$3.01B
Enterprise value
$3B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
6.89
Price to sales (P/S)
5.22
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.22
Earnings
Revenue
$574.5M
EBIT
-$53.05M
EBITDA
-$34.87M
Free cash flow
$1.58M
Per share
EPS
-$1.35
Free cash flow per share
$0.03
Book value per share
$7.46
Revenue per share
$9.84
TBVPS
$5.83
Balance sheet
Total assets
$697.24M
Total liabilities
$262.48M
Debt
$32.72M
Equity
$434.76M
Working capital
$114.61M
Liquidity
Debt to equity
0.08
Current ratio
1.77
Quick ratio
1.32
Net debt/EBITDA
0.24
Margins
EBITDA margin
-6.1%
Gross margin
86.8%
Net margin
-13.7%
Operating margin
-7.6%
Efficiency
Return on assets
-11.6%
Return on equity
-17.8%
Return on invested capital
-28.6%
Return on capital employed
-9.7%
Return on sales
-9.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NARI stock price

How has the Inari Medical stock price performed over time
Intraday
-0.87%
1 week
5.44%
1 month
21.2%
1 year
-2.67%
YTD
-20.84%
QTD
24.61%

Financial performance

How have Inari Medical's revenue and profit performed over time
Revenue
$574.5M
Gross profit
$498.76M
Operating income
-$43.88M
Net income
-$78.58M
Gross margin
86.8%
Net margin
-13.7%
NARI's net income is down by 38% since the previous quarter
Inari Medical's net margin has decreased by 32% from the previous quarter
The operating income has contracted by 26% from the previous quarter
The revenue rose by 22% year-on-year and by 4.9% since the previous quarter

Growth

What is Inari Medical's growth rate over time

Valuation

What is Inari Medical stock price valuation
P/E
N/A
P/B
6.89
P/S
5.22
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.22
The EPS has declined by 38% since the previous quarter
The price to book (P/B) is 44% lower than the 5-year quarterly average of 12.2 but 4.4% higher than the last 4 quarters average of 6.6
The equity is down by 3.8% year-on-year but it is up by 2.6% since the previous quarter
The P/S is 61% below the 5-year quarterly average of 13.4 and 5% below the last 4 quarters average of 5.5
The revenue rose by 22% year-on-year and by 4.9% since the previous quarter

Efficiency

How efficient is Inari Medical business performance
NARI's return on invested capital has dropped by 103% since the previous quarter
The return on sales has declined by 44% since the previous quarter
The return on equity has declined by 39% since the previous quarter
The company's return on assets fell by 30% QoQ

Dividends

What is NARI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NARI.

Financial health

How did Inari Medical financials performed over time
The total assets is 166% greater than the total liabilities
The company's total liabilities has surged by 171% YoY and by 5% QoQ
The quick ratio has plunged by 79% YoY and by 4.3% from the previous quarter
Inari Medical's debt is 92% less than its equity
NARI's debt to equity is up by 14% YoY
The equity is down by 3.8% year-on-year but it is up by 2.6% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.